NASDAQ:CTXR

Citius Pharmaceuticals Stock News

etoro logo Buy CTXR
*Your capital is at risk
$0.580
-0.0230 (-3.81%)
At Close: Jun 03, 2026
Here are the biggest calls on Wall Street on Thursday
Bank to report and disclose the emissions tied to its lending portfolios as it joins Partnership for Carbon Accounting Financials (PCAF)
SHARES of Singapore's local lenders extended their slide on Thursday morning, after the central bank asked them to cap dividend payouts. Read more at The Business Times.
The pair has joined Morgan Stanley among the roster of global banks pledging to measure the impact their lending decisions have on global warming. Citi also said it would finance $250 billion of low-c
The S&P 500 may end 2020 below where it is today, but do you think the U.S. economy will be in a better place in 18 months?
The US dollar has lost ground recently against the major currencies. What is the outlook for a further sell-off? Here is their view, courtesy of eFXdata:
Hong Kong launched a new, Nasdaq-style tech board this week, tracking 30 of the largest tech stocks listed in the city.

As Precious Metals Sizzle, Can Copper Break $3?

12:00am, Wednesday, 29'th Jul 2020
Commodities Analysis by Investing.com (Barani Krishnan/Investing.com) covering: XAU/USD, XAG/USD, Gold Futures, Copper Futures. Read Investing.com (Barani Krishnan/Investing.com)'s latest article on I
Citi Private Bank expects the sector to benefit over the next 12-to-18 months, driven also by long-term trends
The tech index was launched on Monday and tracks the 30 largest technology companies listed in Hong Kong that pass the screening criteria.
The Federal Reserve holds its monthly policy meeting later on Wednesday. What can the markets expect from the FOMC? Here is their view, courtesy of
If you are feeling nervous about the ASX reporting season, you should be as Citigroup is warning that expectations may be set too high.
Weekly update on stockbroker recommendation, target price, and earnings forecast changes
Citius Pharmaceuticals, Inc. ("CITIUS") ("Company") (NASDAQ: CTXR), a specialty pharmaceutical company focused on developing and commercializing critical care drug products, announced today the format
Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a specialty pharmaceutical company focused on developing and commercializing critical care drug products, announced today that
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE